RE:RE:RE:RE:RE:RE:RE:RE:NRsJust like here, bringing up inconvenient facts is considered trolling and bashing, and it is inconceivable to have an independent reasonably critical thought while being a shareholder. Since very few companies are a continual fountain of just good news, that would imply that every shareholder should be a trader. Buy when you hear something good, and then sell when you hear something that concerns you, hoping that you catch the news before the masses and do not sell on the biggest dip. Buy back in when you hear something good hoping that you don't buy too late on a rise, and so it goes....in and out half a dozen times per year. That's not how you usually invest but it seems like that is the way it should go here, except that the formula is unlikely to continue working.
PG does have quite a few fans on the other board though. Some were openly happy to admit how they made good money on the BioCloud and were happy to re-enter upon PG's tweet. They may have made a quick 40-50% before the "corporate update". Good for them, but can't argue how good of a job PG is doing for KNR shareholders,
The saga continues.